Is Kura Oncology, Inc. (KURA) A Good Stock To Buy?
A whopping number of 13F filings filed with U.S.
Kura Oncology Inc. (KURA)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | VenBio Select Advisor Kurt Von Emster | 4,140,000 | $86,319 | +4% | 1.5% |
| 2. | EcoR1 Capital Oleg Nodelman | 3,724,437 | $77,655 | +1% | 2.9% |
| 3. | Holocene Advisors Brandon Haley | 2,587,782 | $53,955 | +16% | 0.3% |
| 4. | Deerfield Management James E. Flynn | 1,794,000 | $37,405 | 0.66% | |
| 5. | Suvretta Capital Management Aaron Cowen | 1,658,706 | $34,584 | +127% | 0.51% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.16 | 83,540 | Large Shareholder | 4,408,097 | 2018-12-21 | Filing | |
| $13.84 | 51,879 | Large Shareholder | 4,324,557 | 2018-12-19 | Filing | |
| $13.82 | 78,469 | Large Shareholder | 4,272,678 | 2018-12-18 | Filing | |
| $13.89 | 25,217 | Large Shareholder | 4,220,729 | 2018-12-13 | Filing | |
| $13.91 | 15,321 | Large Shareholder | 4,195,512 | 2018-12-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $29.43 | 6,250 | Officer | 0 | 2021-03-15 | Filing | |
| $40.60 | 3,125 | Officer | 0 | 2020-12-15 | Filing | |
| $40.60 | 6,250 | Officer | 0 | 2020-12-15 | Filing | |
| $39.43 | 6,250 | Officer | 0 | 2020-11-10 | Filing | |
| $34.00 | 50,370 | Officer, Director | 28,096 | 2020-10-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 838,333 | $15,702 | 0.05% | |
| 2. | 56,635 | $1,060 | 0.29% | |
| 3. | 22,000 | $410 | 0% | |
| 4. | 14,900 | $286 | 0.05% | |
| 5. | 600 | $11 | 0% |
News See All
Is KURA Stock A Buy or Sell?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Is KURA A Good Stock To Buy According To Hedge Funds?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 817 active prominent money managers and analyze their...
Hedge Funds Never Been This Bullish On Kura Oncology, Inc. (KURA)
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Did Hedge Funds Make The Right Call On Kura Oncology, Inc. (KURA) ?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Funds Aren’t Done Buying Kura Oncology, Inc. (KURA)
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
Kura Oncology, Inc. (KURA): Hedge Funds Can’t Make Up Their Minds
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.
Hedge Funds Have Never Been This Bullish On Kura Oncology, Inc. (KURA)
We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th.
Is Kura Oncology, Inc. (KURA) A Good Stock To Buy?
"Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much.
Here’s What Hedge Funds Think About Kura Oncology, Inc. (KURA)
Hedge funds and other investment firms run by legendary investors like Israel Englander, Jeffrey Talpins and Ray Dalio are entrusted to manage billions of dollars of accredited investors' money because...
Billionaire Hedge Funds
